Utility of the EORTC risk tables and CUETO scoring model for predicting recurrence and progression in non-muscle-invasive bladder cancer patients treated with routine second transurethral resection-Reference-Cited by-同舟云学术

Utility of the EORTC risk tables and CUETO scoring model for predicting recurrence and progression in non-muscle-invasive bladder cancer patients treated with routine second transurethral resection

Published:2019-03-25 Issue:12 Volume:37 Page:2699-2705
ISSN:0724-4983
Container-title:World Journal of Urology
language:en
Short-container-title:World J Urol

Author:

Zhang Guoxian^ORCID,Steinbach Daniel,Grimm Marc-Oliver,Horstmann Marcus

Publisher

Springer Science and Business Media LLC

Subject

Urology

Link

http://link.springer.com/content/pdf/10.1007/s00345-019-02681-2.pdf

Reference19 articles.

1. Sievert KD, Amend B, Nagele U, Schilling D, Bedke J, Horstmann M et al (2009) Economic aspects of bladder cancer: what are the benefits and costs? World J Urol 27(3):295–300. https://doi.org/10.1007/s00345-009-0395-z

2. Babjuk M, Böhle A, Burger M, Capoun O, Cohen D, Compérat EM et al (2016) EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder: update 2016. Eur Urol 71(3):447–461. https://doi.org/10.1016/j.eururo.2016.05.041

3. Dobruch J, Borówka A, Herr HW (2014) Clinical value of transurethral second resection of bladder tumour: systematic review. Urology 84(4):881–885. https://doi.org/10.1016/j.urology.2014.06.005

4. Guevara A, Salomon L, Allory Y, Ploussard G, de la Taille A, Paul A et al (2010) The role of tumour-free status in repeat resection before intravesical BCG for high grade Ta, T1 and CIS bladder cancer. J Urol 183(6):2161–2164. https://doi.org/10.1016/j.juro.2010.02.026

5. Herr HW (2011) Role of re-resection in non-muscle invasive bladder cancer. Sci World J 11:283–288. https://doi.org/10.1100/tsw.2011.29

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prediction for recurrent non-muscle invasive bladder cancer;Cancer Biomarkers;2023-11-20

2. Predicting Recurrence and Progression in Patients with Non-Muscle-Invasive Bladder Cancer: Systematic Review on the Performance of Risk Stratification Models;Bladder Cancer;2022-12-14

3. Utility of a Molecular Signature for Predicting Recurrence and Progression in Non-Muscle-Invasive Bladder Cancer Patients: Comparison with the EORTC, CUETO and 2021 EAU Risk Groups;International Journal of Molecular Sciences;2022-11-21

4. Effect of diabetes mellitus and glycemic control on the prognosis of invasive bladder cancer;Pakistan BioMedical Journal;2022-02-25

5. Utility of EORTC and CUETO Scoring Models in the Estimation of Recurrence and Progression of Non-Muscle-Invasive Bladder Cancer;Eurasian Journal of Medicine and Oncology;2022